In the remaining 61 patients (75%), a partial or absent tumor response was observed, with 16 cases (20%) classified as TRG2, 22 cases (27%) classified as TRG3, 21 cases (26%) classified as TRG4 and 2 cases (2%) classified as TRG5 (Fig 1). The gene discussed is LDHB; the disease is neoplasm.